These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20012406)

  • 1. Experimental models of anxiety for drug discovery and brain research.
    Hart PC; Bergner CL; Smolinsky AN; Dufour BD; Egan RJ; Laporte JL; Kalueff AV
    Methods Mol Biol; 2010; 602():299-321. PubMed ID: 20012406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Models of Anxiety for Drug Discovery and Brain Research.
    Hart PC; Bergner CL; Smolinsky AN; Dufour BD; Egan RJ; LaPorte JL; Kalueff AV
    Methods Mol Biol; 2016; 1438():271-91. PubMed ID: 27150096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological modulation of anxiety-related behaviors in the murine Suok test.
    Kalueff AV; Keisala T; Minasyan A; Tuohimaa P
    Brain Res Bull; 2007 Sep; 74(1-3):45-50. PubMed ID: 17683788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models for studying depression-like states and antidepressant drugs.
    Bergner CL; Smolinsky AN; Hart PC; Dufour BD; Egan RJ; Laporte JL; Kalueff AV
    Methods Mol Biol; 2010; 602():267-82. PubMed ID: 20012404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):489-542. PubMed ID: 18615308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of anxiety and benzodiazepine actions.
    Iversen SD
    Arzneimittelforschung; 1980; 30(5a):862-8. PubMed ID: 6106486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of calcium channel blockers on animal behavior in tests to study their anxiolytic activity].
    Kozlovskiĭ VL; Prakh'e IV
    Eksp Klin Farmakol; 1995; 58(1):18-20. PubMed ID: 7787686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
    Patel S; Hillard CJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs.
    Kalueff AV; Tuohimaa P
    Eur J Pharmacol; 2005 Jan; 508(1-3):147-53. PubMed ID: 15680265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The anxiolytic action of an analog of the endogenous peptide tuftsin on inbred mice with different phenotypes of the emotional stress reaction].
    Seredenin SB; Kozlovskaia MM; Blednov IuA; Kozlovskiĭ II; Semenova TP; Czabak-Garbacz R; Nezavibat'ko VN; Miasoedov NF
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(1):153-60. PubMed ID: 9583175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.
    Messaoudi M; Lalonde R; Violle N; Javelot H; Desor D; Nejdi A; Bisson JF; Rougeot C; Pichelin M; Cazaubiel M; Cazaubiel JM
    Br J Nutr; 2011 Mar; 105(5):755-64. PubMed ID: 20974015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of substance P in stress and anxiety responses.
    Ebner K; Singewald N
    Amino Acids; 2006 Oct; 31(3):251-72. PubMed ID: 16820980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse.
    Adriaan Bouwknecht J; Olivier B; Paylor RE
    Neurosci Biobehav Rev; 2007; 31(1):41-59. PubMed ID: 16618509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA/benzodiazepine receptor complex.
    López-Rubalcava C; Piña-Medina B; Estrada-Reyes R; Heinze G; Martínez-Vázquez M
    Life Sci; 2006 Jan; 78(7):730-7. PubMed ID: 16122763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience.
    Adamec R; Head D; Blundell J; Burton P; Berton O
    Physiol Behav; 2006 Jun; 88(1-2):12-29. PubMed ID: 16624347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress.
    Fokos S; Panagis G
    J Psychopharmacol; 2010 May; 24(5):767-77. PubMed ID: 19406854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of psychotropic preparations on the behavior of inbred mice under emotional stress].
    Seredenin SB; Vedernikov AA
    Biull Eksp Biol Med; 1979 Jul; 88(7):38-40. PubMed ID: 37945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.